Finance

Lists
Why is 543904 down ၃.၃၉%?
Dive Deeper
543904:BOM
Mankind Pharma Ltd
၂,၂၇၅.၀၀ ₹
-၃.၃၉%
(-၇၉.၈၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၅၀:၄၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
၂,၃၅၄.၆၀ ₹
High
၂,၃၅၅.၀၀ ₹
Low
၂,၂၆၉.၀၀ ₹
Mkt. cap
ဋေ ၉.၃၇ သ
Avg. vol.
၄.၀၉ သောင်း
Volume
၃.၂၉ သောင်း
P/E ratio
၄၆.၀၃
52-wk high
၂,၆၄၀.၃၀ ₹
52-wk low
၁,၉၀၉.၉၀ ₹
EPS
၄၉.၄၂ ₹
No. of employees
၂ သောင်း
Open
၂,၃၅၄.၆၀ ₹
High
၂,၃၅၅.၀၀ ₹
Low
၂,၂၆၉.၀၀ ₹
Mkt. cap
ဋေ ၉.၃၇ သ
Avg. vol.
၄.၀၉ သောင်း
Volume
၃.၂၉ သောင်း
P/E ratio
၄၆.၀၃
52-wk high
၂,၆၄၀.၃၀ ₹
52-wk low
၁,၉၀၉.၉၀ ₹
EPS
၄၉.၄၂ ₹
No. of employees
၂ သောင်း
News stories
From web sources and news partners
HDFC Sky
HDFC Sky
·
ပြီးခဲ့သည့် ၂ ရက်
Stocks to Watch Today: Wipro, Solar, Agastya, TechM, Mankind
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees၂.၀၅ သောင်း
Founded၁၉၉၁
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၃.၇၀ ထ
ဋေ ၃.၅၇ ထ
ဋေ ၃.၄၄ ထ
ဋေ ၄.၀၃ ထ
Cost of goods sold
ဋေ ၁.၀၆ ထ
၉၇၇.၉၉ ဋေ
ဋေ ၁.၁၇ ထ
ဋေ ၁.၁၀ ထ
Cost of revenue
ဋေ ၁.၀၆ ထ
၉၇၇.၉၉ ဋေ
ဋေ ၁.၁၇ ထ
ဋေ ၁.၁၀ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈၂၅.၁၈ ဋေ
၈၂၃.၇၁ ဋေ
ဋေ ၁.၅၈ ထ
၉၁၃.၅၀ ဋေ
Operating expense
ဋေ ၁.၉၄ ထ
ဋေ ၁.၈၉ ထ
ဋေ ၁.၄၈ ထ
ဋေ ၂.၁၀ ထ
Total operating expenses
ဋေ ၃.၀၀ ထ
ဋေ ၂.၈၇ ထ
ဋေ ၂.၆၅ ထ
ဋေ ၃.၂၀ ထ
Operating income
၆၉၉.၅၁ ဋေ
၆၉၆.၈၃ ဋေ
၇၉၄.၆၈ ဋေ
၈၃၀.၄၉ ဋေ
Other non operating income
၉၁.၈၇ ကုဋေ
၇၂.၇၅ ကုဋေ
-၂၃၁.၀၅ ဋေ
၄၅.၀၀ ကုဋေ
EBT including unusual items
၆၂၄.၀၂ ဋေ
၅၀၉.၀၀ ဋေ
၆၅၉.၁၇ ဋေ
၇၆၉.၄၅ ဋေ
EBT excluding unusual items
၆၂၄.၀၂ ဋေ
၆၁၅.၅၉ ဋေ
၅၅၈.၈၁ ဋေ
၇၆၉.၄၅ ဋေ
Income tax expense
၁၀၃.၈၄ ဋေ
၉၅.၁၂ ကုဋေ
၉၉.၇၅ ကုဋေ
၁၉၅.၃၆ ဋေ
Effective tax rate
၁၆.၆၄%
၁၈.၆၉%
၁၅.၁၃%
၂၅.၃၉%
Other operating expenses
၈၈၈.၄၈ ဋေ
၈၄၆.၀၇ ဋေ
-၃၂၅.၇၈ ဋေ
၉၆၂.၆၃ ဋေ
Net income
၅၁၁.၅၁ ဋေ
၄၀၈.၇၅ ဋေ
၅၅၄.၃၅ ဋေ
၅၆၈.၀၆ ဋေ
Net profit margin
၁၃.၈၄%
၁၁.၄၆%
၁၆.၁၀%
၁၄.၀၉%
Earnings per share
၁၂.၃၈
၁၁.၉၉
၁၃.၈၉
၁၃.၇၄
Interest and investment income
-
-
၅၈.၀၅ ကုဋေ
-
Interest expense
-၁၆၉.၆၈ ဋေ
-၁၅၇.၂၀ ဋေ
-၁၃၅.၈၇ ဋေ
-၁၀၉.၉၈ ဋေ
Net interest expenses
-၁၆၉.၆၈ ဋေ
-၁၅၇.၂၀ ဋေ
-၇၇.၈၂ ကုဋေ
-၁၀၉.၉၈ ဋေ
Depreciation and amortization charges
၂၂၁.၈၂ ဋေ
၂၂၂.၆၀ ဋေ
၂၂၃.၀၈ ဋေ
၂၂၅.၇၀ ဋေ
EBITDA
၉၁၉.၇၆ ဋေ
၈၄၂.၄၉ ဋေ
၉၉၇.၄၂ ဋေ
ဋေ ၁.၀၃ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ